Cargando…

A model of the aged lung epithelium in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is an age-related disorder that carries a universally poor prognosis and is thought to arise from repetitive micro injuries to the alveolar epithelium. To date, a major factor limiting our understanding of IPF is a deficiency of disease models, particularly in vit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaghaghi, Hoora, Cuevas-Mora, Karina, Para, Rachel, Tran, Cara, Roque, Willy, Robertson, Matthew J., Rosas, Ivan O., Summer, Ross, Romero, Freddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312437/
https://www.ncbi.nlm.nih.gov/pubmed/34238764
http://dx.doi.org/10.18632/aging.203291
_version_ 1783729147750645760
author Shaghaghi, Hoora
Cuevas-Mora, Karina
Para, Rachel
Tran, Cara
Roque, Willy
Robertson, Matthew J.
Rosas, Ivan O.
Summer, Ross
Romero, Freddy
author_facet Shaghaghi, Hoora
Cuevas-Mora, Karina
Para, Rachel
Tran, Cara
Roque, Willy
Robertson, Matthew J.
Rosas, Ivan O.
Summer, Ross
Romero, Freddy
author_sort Shaghaghi, Hoora
collection PubMed
description Idiopathic pulmonary fibrosis (IPF) is an age-related disorder that carries a universally poor prognosis and is thought to arise from repetitive micro injuries to the alveolar epithelium. To date, a major factor limiting our understanding of IPF is a deficiency of disease models, particularly in vitro models that can recapitulate the full complement of molecular attributes in the human condition. In this study, we aimed to develop a model that more closely resembles the aberrant IPF lung epithelium. By exposing mouse alveolar epithelial cells to repeated, low doses of bleomycin, instead of usual one-time exposures, we uncovered changes strikingly similar to those in the IPF lung epithelium. This included the acquisition of multiple phenotypic and functional characteristics of senescent cells and the adoption of previously described changes in mitochondrial homeostasis, including alterations in redox balance, energy production and activity of the mitochondrial unfolded protein response. We also uncovered dramatic changes in cellular metabolism and detected a profound loss of proteostasis, as characterized by the accumulation of cytoplasmic protein aggregates, dysregulated expression of chaperone proteins and decreased activity of the ubiquitin proteasome system. In summary, we describe an in vitro model that closely resembles the aberrant lung epithelium in IPF. We propose that this simple yet powerful tool could help uncover new biological mechanisms and assist in developing new pharmacological tools to treat the disease.
format Online
Article
Text
id pubmed-8312437
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-83124372021-07-27 A model of the aged lung epithelium in idiopathic pulmonary fibrosis Shaghaghi, Hoora Cuevas-Mora, Karina Para, Rachel Tran, Cara Roque, Willy Robertson, Matthew J. Rosas, Ivan O. Summer, Ross Romero, Freddy Aging (Albany NY) Research Paper Idiopathic pulmonary fibrosis (IPF) is an age-related disorder that carries a universally poor prognosis and is thought to arise from repetitive micro injuries to the alveolar epithelium. To date, a major factor limiting our understanding of IPF is a deficiency of disease models, particularly in vitro models that can recapitulate the full complement of molecular attributes in the human condition. In this study, we aimed to develop a model that more closely resembles the aberrant IPF lung epithelium. By exposing mouse alveolar epithelial cells to repeated, low doses of bleomycin, instead of usual one-time exposures, we uncovered changes strikingly similar to those in the IPF lung epithelium. This included the acquisition of multiple phenotypic and functional characteristics of senescent cells and the adoption of previously described changes in mitochondrial homeostasis, including alterations in redox balance, energy production and activity of the mitochondrial unfolded protein response. We also uncovered dramatic changes in cellular metabolism and detected a profound loss of proteostasis, as characterized by the accumulation of cytoplasmic protein aggregates, dysregulated expression of chaperone proteins and decreased activity of the ubiquitin proteasome system. In summary, we describe an in vitro model that closely resembles the aberrant lung epithelium in IPF. We propose that this simple yet powerful tool could help uncover new biological mechanisms and assist in developing new pharmacological tools to treat the disease. Impact Journals 2021-07-08 /pmc/articles/PMC8312437/ /pubmed/34238764 http://dx.doi.org/10.18632/aging.203291 Text en Copyright: © 2021 Shaghaghi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Shaghaghi, Hoora
Cuevas-Mora, Karina
Para, Rachel
Tran, Cara
Roque, Willy
Robertson, Matthew J.
Rosas, Ivan O.
Summer, Ross
Romero, Freddy
A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title_full A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title_fullStr A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title_full_unstemmed A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title_short A model of the aged lung epithelium in idiopathic pulmonary fibrosis
title_sort model of the aged lung epithelium in idiopathic pulmonary fibrosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312437/
https://www.ncbi.nlm.nih.gov/pubmed/34238764
http://dx.doi.org/10.18632/aging.203291
work_keys_str_mv AT shaghaghihoora amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT cuevasmorakarina amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT pararachel amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT trancara amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT roquewilly amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT robertsonmatthewj amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT rosasivano amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT summerross amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT romerofreddy amodeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT shaghaghihoora modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT cuevasmorakarina modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT pararachel modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT trancara modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT roquewilly modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT robertsonmatthewj modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT rosasivano modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT summerross modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis
AT romerofreddy modeloftheagedlungepitheliuminidiopathicpulmonaryfibrosis